StandaardVerlies schreef op 23 september 2021 13:05:
Acacia Pharma to Report its Interim Results for the Six Months ended 30 June 2021 on 30 September 2021
Conference Call to be held on 30 September at 14.00 CEST/08.00 EST
Cambridge, UK and Indianapolis, US – 23 September 2021, 13:00 CEST: Acacia Pharma Group plc (“Acacia Pharma” or the "Company”) (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy, announces that it will report its interim results for the half year ended 30 June 2021 at 07.00 CEST on Thursday 30 September.
A presentation by Acacia Pharma’s senior management team will be webcast live the same day at 14.00 CEST (08.00 EST) and will include an update on progress with the US commercialization of Barhemsys® and Byfavo®.
The webcast can be accessed from www.acaciapharma.com
and a recording will be available after the event.
The interim results report will be available at www.acaciapharma.com
in the Investors section from 07.00 CEST on 30 September and slides for the conference call will be made available shortly before the start.
As previously announced, Acacia will also hold a KOL webinar later today at 18.00 CEST/12.00 EDT. Advanced registration is required, and details can be found on our website under the Media/Events section.